Liposomal Bupivacaine for Post-Operative Pain Control in Fragility Intertrochanteric Hip Fractures

AbstractObjectives:Determine whether intraoperative liposomal bupivacaine reduces postoperative opioid requirements, pain scores, and length of stay in patients with fragility intertrochanteric femur fractures in comparison to a group of patients who did not receive liposomal bupivacaine.Design:Retr